Literature DB >> 34276157

Late-Onset Peripheral T-Cell Lymphoma Not Otherwise Specified in a Liver Transplant Recipient: A Rare Subtype of Posttransplant Lymphoproliferative Disorder.

Jagadeesh Menon1, Mukul Vij2, Abdul R Hakeem3, Kakumudi Rajagopal Gopi4, Asma Bibi5, Naresh Shanmugam1, Mettu S Reddy3, Mohamed Rela3,6.   

Abstract

INTRODUCTION: Posttransplant lymphoproliferative disorder (PTLD) is a rare complication seen in the period after liver transplant. The commonest subtype is B-cell PTLD which is usually associated with Epstein-Barr virus (EBV) infection. T-cell PTLD is rare and the association with EBV is again rarer. CASE: Our patient, a 21-year-old young adult, presented to us with generalized lymphadenopathy, 5 years after liver transplantation. The biopsy of the lymph node was suggestive of peripheral T-cell lymphoma not otherwise specified, which was associated with EBV infection. The Positron emission tomography and computerised tomography (PET-CT) scan showed stage 3 disease. He was treated with standard cyclophosphamide, doxorubicin, etoposide, vincristine, and prednisolone chemotherapy and is currently in remission.
CONCLUSION: Peripheral T-cell lymphoma not otherwise specified is a rare subtype of PTLD and its association with EBV is even more rare. A few patients can achieve complete remission with standard chemotherapy.
© 2020 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CHOEP, Cyclophosphamide, Doxorubicin, Etoposide, Vincristine, Prednisolone; EBV, Epstein-Barr Virus; Epstein-Barr virus; NK, Natural Killer Cells; PET, Positron Emission Tomography; PTLD NOS, Posttransplant Lymphoproliferative Disorder Not Otherwise Specified; PTLD, Posttransplant Lymphoproliferative Disorder; chemotherapy; liver transplantation; peripheral T-cell lymphoma not otherwise specified; remission

Year:  2020        PMID: 34276157      PMCID: PMC8267348          DOI: 10.1016/j.jceh.2020.09.002

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  12 in total

1.  Posttransplant lymphoproliferative disorder in pediatric patients.

Authors:  Kais Hussein; Christina Tiede; Britta Maecker-Kolhoff; Hans Kreipe
Journal:  Pathobiology       Date:  2013-08-30       Impact factor: 4.342

2.  Pediatric T-cell post-transplant lymphoproliferative disorder after solid organ transplantation.

Authors:  Fan Yang; Ying Li; Raul Braylan; Stephen P Hunger; Li-Jun Yang
Journal:  Pediatr Blood Cancer       Date:  2008-02       Impact factor: 3.167

3.  Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma.

Authors:  Christian Gisselbrecht; Eric Lepage; Thierry Molina; Bruno Quesnel; Georges Fillet; Pierre Lederlin; Bertrand Coiffier; Hervé Tilly; Jean Gabarre; Francoise Guilmin; Olivier Hermine; Félix Reyes
Journal:  J Clin Oncol       Date:  2002-05-15       Impact factor: 44.544

4.  International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.

Authors:  Julie Vose; James Armitage; Dennis Weisenburger
Journal:  J Clin Oncol       Date:  2008-07-14       Impact factor: 44.544

Review 5.  Epstein-Barr virus infection and posttransplant lymphoproliferative disorder.

Authors:  M Green; M G Michaels
Journal:  Am J Transplant       Date:  2013-02       Impact factor: 8.086

Review 6.  Therapeutic options in relapsed or refractory peripheral T-cell lymphoma.

Authors:  Bertrand Coiffier; Massimo Federico; Dolores Caballero; Claire Dearden; Franck Morschhauser; Ulrich Jäger; Lorenz Trümper; Emanuele Zucca; Maria Gomes da Silva; Ruth Pettengell; Eckhart Weidmann; Francesco d'Amore; Hervé Tilly; Pier Luigi Zinzani
Journal:  Cancer Treat Rev       Date:  2014-08-24       Impact factor: 12.111

7.  T-cell and NK-cell posttransplantation lymphoproliferative disorders.

Authors:  Steven H Swerdlow
Journal:  Am J Clin Pathol       Date:  2007-06       Impact factor: 2.493

Review 8.  Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies.

Authors:  C Agostinelli; P P Piccaluga; P Went; M Rossi; A Gazzola; S Righi; T Sista; C Campidelli; P L Zinzani; B Falini; S A Pileri
Journal:  J Clin Pathol       Date:  2008-08-28       Impact factor: 3.411

Review 9.  Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorders.

Authors:  Qingqing Cai; Kailin Chen; Ken H Young
Journal:  Exp Mol Med       Date:  2015-01-23       Impact factor: 8.718

10.  Post-transplant indolent T cell lymphoproliferative disorder in living donor liver transplantation: a case report.

Authors:  Ryoichi Goto; Norio Kawamura; Masaaki Watanabe; Yasuyuki Koshizuka; Souichi Shiratori; Momoko Ara; Shohei Honda; Tomoko Mitsuhashi; Yoshihiro Matsuno; Tsuyoshi Shimamura; Akinobu Taketomi
Journal:  Surg Case Rep       Date:  2020-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.